Perception of stigma in patients with primary progressive multiple sclerosis.
Francisco Pérez-MirallesDaniel PrefasiAntonio García-MerinoJosé R AraGuillermo IzquierdoVirginia Meca-LallanaFrancisco GascónMaría L Martínez-GinésLluis Ramió-TorrentàLucienne Costa-FrossardÓscar FernándezSara Moreno-GarcíaJorge MaurinoBonaventura Casanova-EstruchPublished in: Multiple sclerosis journal - experimental, translational and clinical (2019)
Stigma associated with neurological disorders may contribute to a poor health-related quality of life. However, limited information is available in primary progressive multiple sclerosis. We investigated the presence and impact of stigma in patients with primary progressive multiple sclerosis. A non-interventional, cross-sectional study was conducted. A total of 55 primary progressive multiple sclerosis patients were studied (mean age 55.8±9.5 years, 56.4% male). The median Expanded Disability Status Scale score was 5.5 (4.0-6.5). Stigma prevalence was 78.2% (n=43). Twenty-four patients (43.6%) were classified as depressed. Scores on the eight-item Stigma Scale for Chronic Illness correlated with physical (rho=0.464, p<0.001) and psychological (rho=0.358, p=0.007) 29-item Multiple Sclerosis Impact Scale subscores. Stigma predicted concurrent depression (odds ratio=1.13; p=0.046). Stigma was highly prevalent with a detrimental effect on quality of life and mood in primary progressive multiple sclerosis.
Keyphrases
- multiple sclerosis
- mental health
- mental illness
- hiv aids
- social support
- white matter
- end stage renal disease
- ejection fraction
- newly diagnosed
- depressive symptoms
- prognostic factors
- physical activity
- sleep quality
- healthcare
- radiation therapy
- peritoneal dialysis
- bipolar disorder
- antiretroviral therapy
- squamous cell carcinoma
- hiv infected
- brain injury
- health information
- protein kinase
- smooth muscle
- patient reported